We are live on ! Find out more
N

Natixis Portfolio holdings

AUM $28B
1-Year Est. Return 26.79%
 

Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.

This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+26.79%
3 Year Est. Return
+97.72%
5 Year Est. Return
+108.83%
10 Year Est. Return
+452.99%
AUM
$13B
AUM Growth
-$2.88B
Cap. Flow
-$3.34B
Cap. Flow %
-25.66%
Top 10 Hldgs %
27.65%
Holding
969
New
188
Increased
241
Reduced
265
Closed
254

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$250M
2
JD icon
JD.com
JD
+$200M
3
MRK icon
Merck
MRK
+$151M
4
AVGO icon
Broadcom
AVGO
+$115M
5
PM icon
Philip Morris
PM
+$102M

Sector Composition

Rank Sector Weight
1 Healthcare 12.69%
2 Communication Services 11.21%
3 Consumer Discretionary 10.35%
4 Financials 10.01%
5 Technology 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BN icon
526
Brookfield
BN
$102B
$1.05M 0.01%
+61,769
New +$1.04M
RCS
527
PIMCO Strategic Income Fund
RCS
$243M
$1.05M 0.01%
+107,833
New +$1.04M
QUOT
528
DELISTED
Quotient Technology Inc
QUOT
$1.04M 0.01%
96,815
-1,710
-2% -$17.3K
DEA
529
Easterly Government Properties
DEA
$1.18B
$1.04M 0.01%
+22,881
New +$1.04M
ROCC
530
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$1.03M 0.01%
+33,513
New +$1.25M
SKYW icon
531
Skywest
SKYW
$4.11B
$1.01M 0.01%
+16,737
New +$991K
BRX icon
532
Brixmor Property Group
BRX
$9.95B
$1.01M 0.01%
+56,374
New +$1.01M
ESNT icon
533
Essent Group
ESNT
$6.06B
$1.01M 0.01%
+21,445
New +$1.01M
ESPR
534
DELISTED
Esperion Therapeutics
ESPR
$1M 0.01%
21,563
+9,095
+73% +$427K
CSIQ icon
535
Canadian Solar
CSIQ
$906M
$982K 0.01%
+45,000
New +$891K
HIG icon
536
Hartford Financial Services
HIG
$38.5B
$969K 0.01%
17,391
-62,527
-78% -$3.3M
XPO icon
537
XPO
XPO
$25B
$966K 0.01%
48,309
-3,013
-6% -$61.4K
WD icon
538
Walker & Dunlop
WD
$1.65B
$964K 0.01%
+18,113
New +$959K
PACB icon
539
Pacific Biosciences
PACB
$422M
$956K 0.01%
+157,976
New +$1.11M
HFBC
540
DELISTED
HopFed Bancorp Inc
HFBC
$948K 0.01%
50,000
CXP
541
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
$945K 0.01%
+45,588
New +$1.01M
QSR icon
542
Restaurant Brands International
QSR
$25.1B
$937K 0.01%
+13,476
New +$902K
IPAR icon
543
Interparfums
IPAR
$3.92B
$936K 0.01%
+14,080
New +$983K
WRK
544
DELISTED
WestRock Company
WRK
$926K 0.01%
25,387
-242,402
-91% -$8.91M
EXEL icon
545
Exelixis
EXEL
$13.9B
$924K 0.01%
+43,242
New +$906K
EXTR icon
546
Extreme Networks
EXTR
$3.86B
$920K 0.01%
+142,209
New +$939K
PBR icon
547
Petrobras
PBR
$121B
$920K 0.01%
59,091
-1,325
-2% -$20.2K
ILF icon
548
iShares Latin America 40 ETF
ILF
$3.77B
$913K 0.01%
+27,066
New +$894K
DELL icon
549
Dell
DELL
$283B
$908K 0.01%
+35,256
New +$1.1M
BSM icon
550
Black Stone Minerals
BSM
$3.11B
$890K 0.01%
57,400

Similar funds

Natixis's Q2 2019 Portfolio in Review

As of Q2 2019, Natixis held 969 positions worth $13B, down 18% from $15.9B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Natixis withdrew a net $3.34B in Q2 2019, closing 254 positions and reducing 265 holdings. Its most notable exit was Amazon, an estimated $339M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 8.4% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Natixis opened a new position in Pfizer worth $258M.

  • Natixis's largest Q2 2019 buy was Pfizer: 6,288,612 shares worth $258M.
  • Natixis added most to JD.com in Q2 2019, an estimated $200M increase.
  • Natixis's biggest Q2 2019 reduction was Meta Platforms (Facebook), cutting an estimated $321M.
  • Natixis fully exited Amazon in Q2 2019, selling an estimated $339M.
  • Natixis's ten largest holdings make up 28% of its $13B portfolio in Q2 2019.
  • Natixis opened 188 new positions and closed 254 in Q2 2019.
  • Natixis's portfolio value fell 18% quarter-over-quarter to $13B.

Based on Natixis's 13F filing for Q2 2019, filed 13 Aug 2019.